Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szekesfehervar

159 clinical trials in Szekesfehervar, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szekesfehervar at a glance
159
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

159 trials in Szekesfehervar

Open in trial search
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:DROSPIRENONE
  • Sponsor:Chemo Research S.L.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.

Other cities in Hungary

The busiest research cities in the country

All 70 cities in Hungary

Clinical research in Szekesfehervar

What the registry says about research in the country

01 Rheumatology and Autoimmune Conditions

Innovative clinical research focusing on psoriatic arthritis, rheumatoid arthritis, and Sjögren's Disease. Studies are evaluating new therapeutic approaches for patients with varying treatment histories.

  • Multiple psoriatic arthritis treatments
  • Novel antibody therapies
  • Autoimmune disease interventions

Research includes investigations of biologics and targeted therapies for patients with inadequate response to conventional treatments.

02 Cardiovascular and Metabolic Disorders

Studies targeting heart failure prevention, cardiovascular disease, and complications of Type 2 Diabetes. Research focuses on innovative therapeutic combinations and preventive strategies.

  • Heart failure risk reduction
  • Cardiovascular outcomes
  • Diabetes management

Trials are investigating novel drug combinations and their impact on major cardiovascular events.

03 Respiratory and Oncology

Advanced research in non-small cell lung cancer and pediatric asthma. Studies are evaluating targeted therapies and innovative treatment approaches.

  • Lung cancer treatments
  • Pediatric respiratory care
  • Post-surgical interventions

Clinical investigations include both early-stage cancer treatments and management of chronic respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).